Drug intelligence / Profile preview

VitaFLUX

Development stage: Unknown
Lead developer: Absorption Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

VitaFLUX is a multi-ingredient dietary supplement developed by Absorption Pharmaceuticals (marketed under the Promescent brand) designed to enhance nitric oxide levels in the body. Its primary formulation includes high doses of L-arginine, L-citrulline, and L-carnitine tartrate, which act as precursors to nitric oxide production. By promoting vasodilation and improving blood flow, VitaFLUX is marketed to support sexual health—specifically erectile function in men and arousal in women—as well as athletic performance and cardiovascular wellness. It is available as an over-the-counter (OTC) product and is often used as a daily supplement to complement other sexual wellness products.

Brand names: VitaFLUX

Targets

NO2- (Nitrite)

Beyond the preview

Go deeper on VitaFLUX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VitaFLUX.

Explore the full profile